Biomolecules and Biomedicine: Reflections on 2024

Reflections on 2024: Progress and Gratitude at Biomolecules and Biomedicine

As 2024 comes to an end, we at Biomolecules and Biomedicine (formerly the Bosnian Journal of Basic Medical Sciences) are proud to share our achievements and express our heartfelt gratitude to the incredible community that makes our progress possible. This year has been filled with milestones, impactful research, and global collaboration.

A Year of Growth: Key Metrics

• CiteScore: Our CiteScore now stands at 7.4, reflecting the quality and relevance of the research we publish.
• Impact Factor: Biomolecules and Biomedicine achieved an impressive Impact Factor of 3.1, a testament to our growing influence in the field.

Efficient and Streamlined Processes

We have made significant strides in enhancing our review and publication process:

• Initial assessment: 2 days (rejection or sending to peer review)
• Peer review duration and final decision: 22 days
• Acceptance to advanced online publication: 2 days
• Average reviews per manuscript: 4

Top Articles of 2024 by Citation Count

We are excited to highlight the most cited articles that have made a significant impact this year:

1. Anti-inflammatory role of fenofibrate in treating diseases
   Authors: Lv Jin […] Songming Huang
   Keywords: Fenofibrate, inflammation, mechanism, peroxisome proliferator-activated receptor-α (PPAR-α), diseases, therapy
2. Serum C-reactive protein to albumin ratio as a reliable marker of diabetic neuropathy in type 2 diabetes mellitus
   Author: Aktas Gulali
   Keywords: Type 2 diabetes mellitus (T2DM), diabetic neuropathy (DN), inflammation, C-reactive protein to albumin ratio (CAR)
3. The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: A literature review
   Authors: Yudi Her Oktaviono […] Ni Made Adnya Suasti
   Keywords: Atherosclerosis, gut microbiome, trimethylamine-N-oxide, coronary artery disease, cardiovascular risk
4. Exogenous spermidine alleviates diabetic cardiomyopathy via suppressing ROS, ERS, and Pannexin-1-mediated ferroptosis
   Authors: Jian Sun […] Hui Yuan
   Keywords: Diabetic cardiomyopathy, Spermidine, ferroptosis, Pannexin-1, P2X7
5. Roxadustat: Do we know all the answers?
   Authors: Qiu-Yu Li […] Wan-Xin Peng
   Keywords: Erythropoietin, HIF-PHI, roxadustat, renal anemia, therapeutic potential

Global Reach

Our journal continues to serve as a platform for diverse voices, with contributions from countries such as China, the USA, Bosnia and Herzegovina, Turkiye, Qatar, Germany, Mexico, Serbia, Canada, India, and many more.

Volume 24: BB Issues One to Six

1. Issue 1, February 2024
2. Issue 2, April 2024
3. Issue 3, June 2024
4. Issue 4, August 2024
5. Issue 5, October 2024
6. Issue 6, December 2024

Celebrating Excellence 

Author of the Year 2024

We are thrilled to recognize Liu Y as the Author of the Year 2024. Their groundbreaking work exemplifies the innovation and quality we strive to promote in biomedical research.

Reviewers of the Month Awards

Our success relies on the dedication of our reviewers. This year, over 1150 reviews were completed, ensuring rigorous peer review and timely publication. We extend our deepest gratitude to the following outstanding reviewers:

1. Fabiano Beraldi Calmasini
2. Amel Dudakovic
3. Eugenia Flores-Alfaro
4. Masaru Tanaka
5. Raquel A. C. Machado
6. Gehan Mohamed Hammad
7. Mirza Pojskic
8. Takahiro Tsujikawa
9. Malik Galijasevic
10. Roozbeh Heidarzadehpilehrood
11. Gizeaddis Lamesgin Simegn
12. Denis Miyashiro

Engaging Content and Accessibility

• Our journal reached over 350,000 readers/month in 2024 across platforms like PubMed Central, our journal’s website, Web of Science, Scopus, and Google Scholar.
• 20,000 registered users now receive our newsletter tailored to their specific fields of interest.
• Indexed in premier platforms including SCIE, Web of Science, PubMed, SCOPUS, and more.

Exciting Thematic Issues

We invite submissions for our upcoming thematic issues, including:

• Artificial Intelligence and Machine Learning in Disease Diagnosis and Treatment Target Identification
• Insulin for Type 1 and Type 2 Diabetes Mellitus: Pathophysiology, Complications, and Treatment
• Cell-based Therapeutics

Looking Ahead to 2025

We eagerly anticipate another year of impactful research and collaboration. Whether you’re an author, reviewer, or reader, we encourage your continued participation in advancing biomedical science.

---

We thank you for being an integral part of our journey. Your contributions inspire us, and we look forward to achieving even greater heights together in 2025.

Warmest regards,

Biomolecules and Biomedicine team

 

Editor: Merima Hadžić